{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:09:06Z","timestamp":1757700546521,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institutional National Research Service","award":["T32 HP10025B0 (Baltimore, MD)"],"award-info":[{"award-number":["T32 HP10025B0 (Baltimore, MD)"]}]},{"name":"NIH-NHLBI","award":["2T32HL007180-41A1 (Baltimore, MD)"],"award-info":[{"award-number":["2T32HL007180-41A1 (Baltimore, MD)"]}]},{"name":"NIH-NIDDK Renal Disease Epidemiology Training","award":["T32DK007732-20"],"award-info":[{"award-number":["T32DK007732-20"]}]},{"name":"NIH-NHLBI","award":["7K23HL135273-02 (Boston, MA)"],"award-info":[{"award-number":["7K23HL135273-02 (Boston, MA)"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.amjcard.2018.06.041","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T17:23:26Z","timestamp":1530725006000},"page":"1185-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure &lt;120mm Hg Versus 135-139mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-9597","authenticated-orcid":false,"given":"Timothy B.","family":"Plante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Juraschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Edgar R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Littenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.06.041_bib0001","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"a randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0002","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the systolic blood pressure intervention trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials Lond Engl"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0003","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0005","unstructured":"SPRINT Executive Committee. Systolic Blood Pressure Intervention Trial (SPRINT): Protocol Version 4.0. 2012. Available at: https:\/\/www.sprinttrial.org\/public\/Protocol_Current.pdf. Accessed June 14, 2018."},{"key":"10.1016\/j.amjcard.2018.06.041_bib0006","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"year":"2015","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","key":"10.1016\/j.amjcard.2018.06.041_bib0007"},{"journal-title":"Hypertension","year":"2017","author":"Whelton","key":"10.1016\/j.amjcard.2018.06.041_bib0008"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0009","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"FGR","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0011","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.2012.9630","article-title":"Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis","volume":"308","author":"Den Ruijter","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0012","article-title":"Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events","volume":"5","author":"Schnell-Inderst","year":"2009","journal-title":"GMS Health Technol Assess"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0013","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2018.01.074","article-title":"Impact of cardiovascular risk on the relative benefit and harm of intensive treatment of hypertension","volume":"71","author":"Phillips","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0014","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2018.1536","article-title":"The proposal to lower P value thresholds to .005","volume":"319","author":"Ioannidis","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.06.041_bib0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2015.10.037","article-title":"Generalizability of SPRINT results to the U.S. adult population","volume":"67","author":"Bress","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491831333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491831333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T03:22:53Z","timestamp":1604546573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491831333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S000291491831333X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.041","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120mm Hg Versus 135-139mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}